Literature DB >> 15308697

Retroviral vectors pseudotyped with severe acute respiratory syndrome coronavirus S protein.

Tsanan Giroglou1, Jindrich Cinatl, Holger Rabenau, Christian Drosten, Harald Schwalbe, Hans Wilhelm Doerr, Dorothee von Laer.   

Abstract

The worldwide outbreak of severe acute respiratory syndrome (SARS) was shown to be associated with a novel coronavirus (CoV) now called SARS CoV. We report here the generation of SARS CoV S protein-pseudotyped murine leukemia virus (MLV) vector particles. The wild-type S protein pseudotyped MLV vectors, although at a low efficiency. Partial deletion of the cytoplasmic tail of S dramatically increased infectivity of pseudotypes, with titers only two- to threefold lower than those of pseudotypes generated in parallel with the vesicular stomatitis virus G protein. S-pseudotyped MLV particles were used to analyze viral tropism. MLV(SARS) pseudotypes and wild-type SARS CoV displayed similar cell types and tissue and host restrictions, indicating that the expression of a functional receptor is the major restraint in permissiveness to SARS CoV infection. Efficient gene transfer could be detected in Vero and CaCo2 cells, whereas the level of gene marking of 293T, HeLa, and HepG2 cells was only slightly above background levels. A cat cell line and a dog cell line were not susceptible. Interestingly, PK-15, a porcine kidney cell line, and primary porcine kidney cells were also highly permissive for SARS S pseudotypes and wild-type SARS CoV. This finding suggests that swine may be susceptible to SARS infection and may be a source for infection of humans. Taken together, these results indicate that MLV(SARS) pseudotypes are highly valuable for functional studies of viral tropism and entry and, in addition, can be a powerful tool for the development of therapeutic entry inhibitors without posing a biohazard to human beings.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15308697      PMCID: PMC506966          DOI: 10.1128/JVI.78.17.9007-9015.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

2.  Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence.

Authors:  T Cathomen; H Y Naim; R Cattaneo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

3.  Pseudotyping of murine leukemia virus with the envelope glycoproteins of HIV generates a retroviral vector with specificity of infection for CD4-expressing cells.

Authors:  B S Schnierle; J Stitz; V Bosch; F Nocken; H Merget-Millitzer; M Engelstädter; R Kurth; B Groner; K Cichutek
Journal:  Proc Natl Acad Sci U S A       Date:  1997-08-05       Impact factor: 11.205

4.  High-level gene transfer to cord blood progenitors using gibbon ape leukemia virus pseudotype retroviral vectors and an improved clinically applicable protocol.

Authors:  M Movassagh; C Desmyter; C Baillou; S Chapel-Fernandes; M Guigon; D Klatzmann; F M Lemoine
Journal:  Hum Gene Ther       Date:  1998-01-20       Impact factor: 5.695

5.  Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.

Authors:  D Lindemann; M Bock; M Schweizer; A Rethwilm
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

6.  Noninfectious virus-like particles produced by Moloney murine leukemia virus-based retrovirus packaging cells deficient in viral envelope become infectious in the presence of lipofection reagents.

Authors:  S Sharma; F Murai; A Miyanohara; T Friedmann
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-30       Impact factor: 11.205

7.  Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1998-04       Impact factor: 5.103

8.  Truncation of the cytoplasmic domain of the simian immunodeficiency virus envelope glycoprotein increases env incorporation into particles and fusogenicity and infectivity.

Authors:  K Zingler; D R Littman
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery.

Authors:  R Zufferey; T Dull; R J Mandel; A Bukovsky; D Quiroz; L Naldini; D Trono
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

10.  Targeted recombination within the spike gene of murine coronavirus mouse hepatitis virus-A59: Q159 is a determinant of hepatotropism.

Authors:  I Leparc-Goffart; S T Hingley; M M Chua; J Phillips; E Lavi; S R Weiss
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

View more
  69 in total

Review 1.  The molecular biology of coronaviruses.

Authors:  Paul S Masters
Journal:  Adv Virus Res       Date:  2006       Impact factor: 9.937

2.  Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry.

Authors:  Rene Broer; Bertrand Boson; Willy Spaan; François-Loïc Cosset; Jeroen Corver
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

3.  Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting.

Authors:  Jean K Millet; Tiffany Tang; Lakshmi Nathan; Javier A Jaimes; Hung-Lun Hsu; Susan Daniel; Gary R Whittaker
Journal:  J Vis Exp       Date:  2019-03-01       Impact factor: 1.355

4.  Human coronavirus NL63 employs the severe acute respiratory syndrome coronavirus receptor for cellular entry.

Authors:  Heike Hofmann; Krzysztof Pyrc; Lia van der Hoek; Martina Geier; Ben Berkhout; Stefan Pöhlmann
Journal:  Proc Natl Acad Sci U S A       Date:  2005-05-16       Impact factor: 11.205

5.  The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein.

Authors:  Corrin E McBride; Jie Li; Carolyn E Machamer
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

6.  Functional characterization of heptad repeat 1 and 2 mutants of the spike protein of severe acute respiratory syndrome coronavirus.

Authors:  Woan-Eng Chan; Chin-Kai Chuang; Shiou-Hwei Yeh; Mau-Sun Chang; Steve S-L Chen
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

7.  Mutations in gp120 contribute to the resistance of human immunodeficiency virus type 1 to membrane-anchored C-peptide maC46.

Authors:  Felix G Hermann; Lisa Egerer; Frances Brauer; Christian Gerum; Harald Schwalbe; Ursula Dietrich; Dorothee von Laer
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

8.  Aromatic amino acids in the juxtamembrane domain of severe acute respiratory syndrome coronavirus spike glycoprotein are important for receptor-dependent virus entry and cell-cell fusion.

Authors:  Megan W Howard; Emily A Travanty; Scott A Jeffers; M K Smith; Sonia T Wennier; Larissa B Thackray; Kathryn V Holmes
Journal:  J Virol       Date:  2008-01-16       Impact factor: 5.103

9.  Deletion of the SARS-CoV-2 Spike Cytoplasmic Tail Increases Infectivity in Pseudovirus Neutralization Assays.

Authors:  Jingyou Yu; Zhenfeng Li; Xuan He; Makda S Gebre; Esther A Bondzie; Huahua Wan; Catherine Jacob-Dolan; David R Martinez; Joseph P Nkolola; Ralph S Baric; Dan H Barouch
Journal:  J Virol       Date:  2021-03-16       Impact factor: 6.549

10.  Remission of invasive, cancer stem-like glioblastoma xenografts using lentiviral vector-mediated suicide gene therapy.

Authors:  Peter C Huszthy; Tsanan Giroglou; Oleg Tsinkalovsky; Philipp Euskirchen; Kai Ove Skaftnesmo; Rolf Bjerkvig; Dorothee von Laer; Hrvoje Miletic
Journal:  PLoS One       Date:  2009-07-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.